China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Down 7.3 %

Shares of CPHI opened at $0.30 on Friday. China Pharma has a 52 week low of $0.27 and a 52 week high of $2.70. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.88 and a quick ratio of 0.33. The business’s 50 day moving average price is $0.37 and its 200-day moving average price is $0.47.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.